ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $10,000 | +66.7% | 533 | +4.9% | 0.00% | – |
Q2 2019 | $6,000 | -14.3% | 508 | 0.0% | 0.00% | – |
Q1 2019 | $7,000 | +75.0% | 508 | +35.8% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 374 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | 0.0% | 374 | 0.0% | 0.00% | – |
Q2 2018 | $6,000 | +20.0% | 374 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | – | 374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |